WHO ICTRP trial
PET Imaging to diagnose of inclassificable parkinsonism
EUCTR2012-000364-21-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-000364-21-ES |
|---|---|
| Public title | PET Imaging to diagnose of inclassificable parkinsonism |
| Scientific title | FDDNP-PET FOR IN VIVO DIAGNOSIS OF TAUOPATHY IN UNCLASSIFIABLE PARKINSONISM |
| Primary sponsor | Fundació Clínic per a la Recerca Biomédica |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Atypical Parkinsonism MedDRA version: 14.1 Level: PT Classification code 10034010 Term: Parkinsonism System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Product Name: [18F]-Fluoro-ethyl-methyl-amino-naphthyl-ethylidene-malononitrile (FDDNP Product Code: FDDNP Pharmaceutical Form: Injection INN or Proposed INN: [18F]-Fluoro-ethyl-methyl-amino-naphthyl-ethylidene-malononitrile Other… |
| Registration date | Sep 8, 2012 |
| Secondary IDs | PI1102031 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: